Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis

7Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis is an autosomal-recessive disease caused by mutations in the CLDN16 or CLDN19 genes, which encode tight junction-associated proteins, claudin-16 and-19. The resultant tubulopathy leads to urinary loss of Mg2 and Ca 2, with subsequent nephrocalcinosis and end-stage renal disease (ESRD). An 18-year-old boy presented with chronic kidney disease and proteinuria, as well as hypomagnesaemia, hypercalciuria and nephrocalcinosis. A kidney biopsy revealed tubular atrophy, interstitial fibrosis and segmental sclerosis of some glomeruli. Two novel mutations in the CLDN16 gene were identified: c.340C>T (nonsense) and c.4275G>A (splice site). The patient reached ESRD at 23 and benefited from kidney transplantation. © 2014 The Author 2014.

Cite

CITATION STYLE

APA

Hanssen, O., Castermans, E., Bovy, C., Weekers, L., Erpicum, P., Dubois, B., … Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. Clinical Kidney Journal, 7(3), 282–285. https://doi.org/10.1093/ckj/sfu019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free